---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-159193"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:08:26.398482+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# IO Biotech stockholders elect three directors and ratify EY as auditor at 2024 annual meeting

## Summary
- Kathleen Sereda Glaub, Peter Hirth, and Mai-Britt Zocca elected as Class III directors until 2027.
- Votes for each director exceeded 42 million; broker non-votes 3.9 million on each.
- Ratification of EY as independent auditor for FY 2024 approved with 47.2 million for, 67k against.
- No other matters were voted on at the June 6, 2024 annual meeting.

## SEC filing metadata
- accession: 0001193125-24-159193
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/0001193125-24-159193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/d768244d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-159193
- JSON: https://secwatch.observer/filing/0001193125-24-159193.json
- Plain text: https://secwatch.observer/filing/0001193125-24-159193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.